---
figid: PMC6920345__41419_2019_2192_Fig3_HTML
figtitle: The impact of oncogenic RAS on redox balance and implications for cancer
  development
organisms:
- Homo sapiens
- Mus musculus
- Danio rerio
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
- Drosophila melanogaster
pmcid: PMC6920345
filename: 41419_2019_2192_Fig3_HTML.jpg
figlink: /pmc/articles/PMC6920345/figure/Fig3/
number: F3
caption: Oncogenic RAS drives multiple antioxidant programs by altering intracellular
  metabolism, such as by driving GSH and NADPH production via the TCA cycle, by generating
  NAPDH through an alternative glutamine metabolic pathway mediated by aspartate aminotransferase
  (GOT1), or potentially by generating NADPH via a fatty acid oxidation pathway mediated
  by acyl-coenzyme A (CoA) synthetase long-chain family member 3 (ACSL3). In addition,
  oncogenic RAS upregulates several key antioxidant proteins, including the light-chain
  subunit of the system xc− transporter (xCT), nuclear factor, erythroid 2-like 2
  (NRF2), and gamma-glutamyltransferase 2 (GGT2).
papertitle: The impact of oncogenic RAS on redox balance and implications for cancer
  development.
reftext: Jonathan K. M. Lim, et al. Cell Death Dis. 2019 Dec;10(12):955.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9563452
figid_alias: PMC6920345__F3
figtype: Figure
redirect_from: /figures/PMC6920345__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6920345__41419_2019_2192_Fig3_HTML.html
  '@type': Dataset
  description: Oncogenic RAS drives multiple antioxidant programs by altering intracellular
    metabolism, such as by driving GSH and NADPH production via the TCA cycle, by
    generating NAPDH through an alternative glutamine metabolic pathway mediated by
    aspartate aminotransferase (GOT1), or potentially by generating NADPH via a fatty
    acid oxidation pathway mediated by acyl-coenzyme A (CoA) synthetase long-chain
    family member 3 (ACSL3). In addition, oncogenic RAS upregulates several key antioxidant
    proteins, including the light-chain subunit of the system xc− transporter (xCT),
    nuclear factor, erythroid 2-like 2 (NRF2), and gamma-glutamyltransferase 2 (GGT2).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Acsl3
  - Zhx2
  - Got1
  - Decr1
  - Ephb2
  - Mapk1
  - Gnat2
  - Ets1
  - Jun
  - Atf4
  - Myc
  - Nol3
  - Mal
  - Tirap
  - Mrtfa
  - Nfe2l2
  - Slc7a11
  - Hmox1
  - Gclc
  - Ggt1
  - Pggt1b
  - KRAS
  - HRAS
  - NRAS
  - ACSL3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - GOT1
  - GOLT1B
  - GOLT1A
  - GGT2P
  - DECR1
  - EPHB2
  - MAPK1
  - MAPK3
  - ETS1
  - JUN
  - JUNB
  - JUND
  - ATF4
  - MYC
  - MAL
  - MRTFA
  - TIRAP
  - PNMA1
  - GSTZ1
  - GABPA
  - NFE2L2
  - SLC7A11
  - HMOX1
  - GCLC
  - GGT1
  - rab1ab
  - acsl3b
  - got1
  - got1l1
  - ets1
  - jun
  - atf4a
  - myca
  - mycbp2
  - tirap
  - malb
  - nfe2l2a
  - hmox1a
  - gclc
  - ggt1a
  - Ras64B
  - Ras85D
  - Vha26
  - Acsl
  - Raf
  - Erk7
  - rl
  - CycE
  - cyc
  - Jra
  - crc
  - mal
  - bs
  - Mrtf
  - Keap1
  - cnc
  - pyr
  - Ggt-1
  - betaggt-I
  - Glu
  - NADPH
  - TCA
  - Asp
  - NADH
  - NAD
  - NADP
  - GSH
---
